160 likes | 594 Views
Emerging Biotech Industry in Shenzhen High-Tech industrial Park Shenzhen China. 3/29/2006. The output is RMB 492.690 billion in total last year in SZ. GDP/c is $ 7850. The foreign trade volume is $182.860 billion. It’s the No.1 place in China in the last 13 years.
E N D
Emerging Biotech Industry in Shenzhen High-Tech industrial Park Shenzhen China 3/29/2006
The output is RMB 492.690 billion in total last year in SZ. GDP/c is $ 7850. • The foreign trade volume is $182.860 billion. It’s the No.1 place in China in the last 13 years. • The harbor container is 16.1968 million of standard containers/yr that ranks No.4 in the world. About Shenzhen • The GDP in China in 2005 is 9.9% equal to RMB 18.2321 trillion. • GDP/capita is $1703.
The pharmaceutical industry in China • The output of pharmaceutical industry last year in China is about RMB 528.1 billion with 17.46% growth rate. • IP protection in China is playing more important role than ever before in the market. • Raw medical material continue to have great competitive advantages.
The pharmaceutical industry in China 2003—2005 IND APPROVALS IN CHINA
Development of Shenzhen’s Biomedicine industry • High-tech products provide substantial value that is RMB 490.0 billion. Government provide strong support in this field. • The biomedicine industry in Shenzhen last year produces around RMB 20.0 billion. • The medicines is 15.1 billion and medical equipment is RMB 4.9 billion. • Shenzhen ranks No.3 in all cities both in biomedicine industry and pharmaceutical industry in China.
Development of Shenzhen’s Biomedicine industry Introduction about the industry • There are 74 pharmaceutical corporations were awarded the certificate for manufacturing medicine. • We have 353 medical equipment corporations and 646 pharmaceutical business corporations by the end of 2005. • 4 corporations with annual sales of biomedicines and medical instruments over RMB 1 billion. • 19 ones between RMB 0.1 and 1 billion. • 64 ones between RMB 10,00 million and 100 million. • About 20 products ranks No.1 in China, 11 biomedicines are recognized as the example in the State high-tech industry.
Development of Shenzhen’s Biomedicine industry Introduction about the industry • Biomedicine industry in SZ focuses on local medicines with strong IP ownership. • We have many national pharmaceutical corporations grew up in Shenzhen, such as Neptunus, Sibiono, Kexing, Hepalink, Xinpeng, Mindray, Hybio, Kangtai, Suanjiu and Joincare and Accord. • We also have many corporations of foreign country in Shenzhen, such as Novonordisk ,Tsumura medicine.
Development of Shenzhen’s Biomedicine industry Introduction of Product Main types of medicines: (1)Chinese medicines, (2)Chemical medicines, (3)Biomedicines Main medical instruments: (1) Electric instruments for medicines; (2) Instrument for medical photography diagnosis; (3) Intervention treatment product; (4) Household medical instruments; (5) Instruments for radiation therapy; (6) Healthy consumable materials
Development of Shenzhen’s Biomedicine industry Advantages about the Industry • Shenzhen government decided to put biotech as the key industry and provide strong support in government policy such as fund and land. • Lots talents on biotechnology R& D to establish business in Shenzhen. • A batch of products with technology internally domestically first grade were developed successfully in Shenzhen.
Development of Shenzhen’s Biomedicine industry Features of Industrious Development
Development of Shenzhen’s Biomedicine industry Features of Industrious Development
Development of Shenzhen’s Biomedicine industry Features of Industrious Development
Development of Shenzhen’s Biomedicine industry Features of Industrious Development
Development of Shenzhen’s Biomedicine industry Features of Industrious Development
Development of Shenzhen’s Biomedicine industry Development Planning • Shenzhen as one of the 3 cities (Changchun, Shijiazhuang and Shenzhen) in the first batch of the State biomedicine production base • There are 28 projects in key biomedicine industry approved The total investment is up to RMB 6.5472 billion • Earlier this year, Shenzhen issued the bill implementing innovative strategy to build a new type city • Shenzhen biomedicine industry output value will be between RMB 70 -100 billion until 2010